Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The 5,10-MTHFR 677C>T and RFC1 80G>A polymorphisms are associated with an increased risk of susceptibility to pediatric ALL. 31499477

2019

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Our findings suggest that C677T polymorphism of MTHFR seems to be a good marker for MTX-related toxicity in ALL. 30545275

2019

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE We observed a significant decrease in risk for the C677T polymorphism (OR range=0.54-0.75, p<0.01) and a significant increase in risk for the A1298C polymorphism (OR range=1.28-2.52, p<0.05) in developing ALL for all genetic models. 31188929

2019

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Therefore, <i>MTHFR</i> C677T and A1298C polymorphisms do not seem to be good markers of MTX-related toxicity and/or outcome in pediatric ALL. 28392709

2017

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The MTHFR C677T and A1298C genotypes were analyzed using allele discrimination tests with Taq-Man fluorescent probes.The MTHFR 677TT genotype was related to a 2-fold increase in risk of ALL (P = .014). 29390492

2017

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE In summary, this meta-analysis suggests that MTHFR C677T polymorphism is associated with increased breast cancer, gastric cancer, and hepatocellular cancer risk in Asians, is associated with increased gastric cancer, multiple myeloma, and NHL risk in Caucasians, is associated with decreased AALL risk in Caucasians, is associated with decreased CALL risk in Asians, is associated with increased breast cancer risk in Asians, is associated with decreased colon cancer risk, and is associated with decreased colorectal cancer risk in male population. 26081619

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The aim of our study was to investigate the influence of C677T and A1298C polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene on MTX-induced toxicity during treatment of children with ALL. 26528799

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The aims of this study were to (a) to determine the prevalence of seven common genetic polymorphisms including those that affect the folate and/or thiopurine metabolic pathways, i.e. cyclin D1 (CCND1-G870A), γ-glutamyl hydrolase (GGH-C452T), methylenetetrahydrofolate reductase (MTHFR-C677T and MTHFR-A1298C), thymidylate synthase promoter (TYMS-TSER), thiopurine methyltransferase (TPMT*3A and TPMT*3C) and inosine triphosphate pyrophosphatase (ITPA-C94A), in Caucasian (n = 94, age < 20) and Vietnamese (n = 141, age < 16 years) childhood ALL and (b) to assess the impact of a multilocus genetic risk score (MGRS) on relapse-free survival (RFS) using a Cox proportional-hazards regression model. 25099492

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE No significant differences were found between patients with ALL and controls for the frequency of MTHFR C677T and A1298C alleles, genotypes, combined genotypes or haplotypes. 25629981

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Our results indicated that the MTHFR C677T T allele was a protective biomarker for childhood ALL in Taiwan, and the association was more significant in male patients and in patients 3.5 years of age or older at onset of disease. 25793509

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE In a case-control study of 203 patients with ALL and 246 controls and meta-analysis in the Indian population, we showed an insignificant association of MTHFR C677T and A1298C genotypes with childhood and adult ALL. 25115513

2015

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE In conclusion, the MTHFR C677T and A1298C haplotypes might be useful for monitoring adverse effects in childhood ALL maintenance therapy in Japanese patients. 23865834

2014

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review. 23550988

2014

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE These findings confirm that the MTHFR C677T polymorphism could be considered as a good marker of the pediatric ALL relapse risk. 24637499

2014

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Our results suggest that the MTHFR C677T and A1298C polymorphisms may be potential biomarkers for ALL risk in Chinese populations, and studies with a larger sample size and wider population spectrum are required before definitive conclusions can be drawn. 25342508

2014

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE This meta-analysis supports the idea that the MTHFR C677T genotype is associated with risk of ALL in Caucasians. 24377532

2013

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE In conclusion, MTHFR, C677T and A1298C polymorphisms do not seem to be good markers of MTX-related toxicity in pediatric ALL. 23089671

2013

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE In the adult subgroup, there was no significant association between the C677T variant and ALL risk (Dominant model: OR(RE)=0.88, 95% CI: 0.45-1.72, p=0.72). 23061880

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE 5,10-methylenetetrahydrofolate reductase (MTHFR) variants, C677T and A1298C, have been reported to be associated with decreased risk of acute lymphoblastic leukemia (ALL). 22943282

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Seventy-two children with ALL and 109 age- and sex-matched healthy children from Western Iran were screened for MTHFR C677T and A1298C variants by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). 22017305

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The genetic association studies (GAS) that investigated the association between ALL and the MTHFR C677T and A1298C gene variants have produced contradictory or inconclusive results. 22094326

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE These results suggest that the MTHFR C677T, but not A1298C, polymorphism is a potential biomarker for childhood ALL risk. 21495160

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Genotyping of MTHFR polymorphism, C677T particularly, prior to treatment for ALL is likely to be useful with the aim of tailoring MTX therapy and thus reducing the MTX-related toxicities. 22528943

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE Children with ALL (n = 96) were screened for GCPII C1561T, RFC1 G80A, cSHMT C1420T, TYMS 5´-UTR 2R3R, TYMS 3´-UTR ins6/del6, MTHFR C677T, MTR A2756G polymorphisms using PCR-RFLP and PCR-amplified fragment length polymorphism techniques. 22838948

2012

dbSNP: rs1217691063
rs1217691063
Childhood Acute Lymphoblastic Leukemia
0.100 GeneticVariation BEFREE The MTHFR 677C>T SNP and the MTRR 66A >G SNP were identified as determinants of impaired BMD(TB) in childhood ALL patients. 20955826

2011